Brief Intervention in Primary Care for Problem Drug Use and Abuse
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
This study will examine the effectiveness of a brief intervention in a primary care setting to reduce drug use or abuse compared to enhanced care as usual.
Full description
A substantial body of research has established the efficacy and effectiveness of brief interventions (BI) for excessive or "hazardous" alcohol use in patients seen in medical settings. Dissemination projects of brief interventions for alcohol and drugs have recently been implemented on a widespread scale. This rapid progression of brief intervention for drugs other than alcohol has outstripped its evidence base.
The aims of the study as outlined in the grant are:
To examine whether BI is effective at improving outcomes (self-reported drug use and attendance in drug abuse treatment) in individuals with a wide range of problem drug use over and above enhanced care as usual. The enhanced control condition will consist of routine screening, patient notification, and referral for treatment. To test whether fidelity to the BI model or lower severity of drug use is associated with better outcomes. To estimate the impact of BI on several public health outcomes that are directly related to the hazardous effects of illicit drug use, including the use of acute health care services, involvement in the criminal justice system, employment, HIV risk behavior, and mortality. To estimate the costs of the intervention, potential cost offsets, and its incremental cost-effectiveness versus enhanced usual care from the payer perspective based on health care service use and drug use frequency.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- at least 18 years old
- receive medical care at one of the participating primary care clinics at Harborview Medical Center/University of Washington Medical Center
- will maintain care at the clinic for one year
- have a phone or easy access to phone, voicemail, or email
- used recreational drugs in the last 3 months
- used prescription medications not as prescribed in the last 3 months
Exclusion criteria
- participation in any formal substance abuse treatment programs in the last 30 days (excluding 12-step or self-help groups)
- terminal illness
Trial design
Primary purpose
Allocation
Interventional model
Masking
868 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal